Newsroom

Sorted by: Latest
-

Master Plan Communications Launches Material Handling Marketing Insights Video Series: “Handle More Business”

IRVING, Texas & RANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--MPC announces its “Handle More Business” video series released on the third Thursday of every month...
-

ESS Appoints Randall Selesky as Chief Commercial Officer to Accelerate Global Growth

WILSONVILLE, Ore.--(BUSINESS WIRE)--ESS Appoints Randall Selesky as Chief Commercial Officer to Accelerate Global Growth...
-

I/O Fund Proves Leadership in AI Stocks with 326% Cumulative Return and 29.2% Annualized Return

BOULDER, Colo.--(BUSINESS WIRE)--The I/O Fund has achieved a 326% cumulative return since its May 2020 debut, representing a 4.26x multiple. The team’s 29.2% annualized return has outpaced both broad market indexes and institutional tech-focused funds. In another year of strong relative outperformance, the I/O Fund achieved a 37% portfolio return in 2025. When excluding cryptocurrency, the team’s equity strategy delivered a staggering 56% return, a result that ranks the I/O Fund team among the...
-

Vonage élargit son écosystème de développeurs pour accélérer la prochaine ère de transformation numérique des entreprises

HOLMDEL, New Jersey--(BUSINESS WIRE)--Vonage, filiale d’Ericsson (NASDAQ : ERIC), a annoncé aujourd’hui plusieurs nouvelles initiatives visant à élargir et à renforcer sa communauté mondiale de développeurs. En développant sa communauté de développeurs et ses outils, en donnant aux développeurs et aux entreprises accès à de nouvelles informations et fonctionnalités sur les réseaux mobiles pouvant être intégrées dans les applications et les flux de travail existants, Vonage accélère sa stratégie...
-

NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis

MALVERN, Pa.--(BUSINESS WIRE)--NexEos Bio Vision Health (“NexEos”), a clinical-stage biopharmaceutical company developing novel therapies and diagnostics targeting eosinophil-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared NexEos’s Investigational New Drug (IND) Application to proceed to a Phase II/III clinical trial of NTX-1024 for the treatment of patients with the rare disease, vernal keratoconjunctivitis (VKC). The planned Phase II/III trial i...
-

New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer

SAN ANTONIO, Texas--(BUSINESS WIRE)--In new case study, CyPath Lung spares elderly woman from an invasive procedure for a suspicious lung nodule discovered on a CT scan....
-

Keysight Introduces Infiniium XR8 Oscilloscopes to Accelerate High-Speed Digital Validation and Compliance

SANTA ROSA, Calif.--(BUSINESS WIRE)--Next-generation architecture delivers faster analysis, clearer insights, and a compact design to turn days of digital validation into hours....
-

Dataiku Earns Spot on G2’s 2026 Best Software Awards for Best Data Analytics Software Products

NEW YORK--(BUSINESS WIRE)--Dataiku, the AI platform powering some of the world’s leading organizations, today announced it has been named to G2’s 2026 Best Software Awards, placing #33 on the Best Analytics Software Products list. As the world’s largest and most trusted software marketplace, G2 reaches over 100 million buyers annually. Its annual Best Software Awards rank the world’s best software companies and products based on authentic, timely reviews from real users. The recognition in G2’s...
-

BZI® Announces Thomas Harker as President, New Executive Leadership Roles Across Its Companies, and Updated Branding

KANARRAVILLE, Utah--(BUSINESS WIRE)--BZI® names Thomas Harker as President; new leadership roles across the company and affiliates; and rebrands two of its affiliate operations....
-

New Gradient AI Solution Provides AI-Powered Workers’ Compensation Claims Benchmarking for Brokers

BOSTON--(BUSINESS WIRE)--Gradient AI’s ClaimVector benchmarking solution is grounded in real claims data – providing defensible, data-driven decision-making....